Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Rockwell Medical Inc's Business Segments
Rockwell Medical Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 17
Regions Reported
1
Revenue Share by Reportable Segment - Q1 FY2026
- Reportable0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 17 | - |
Revenue Share by Region - Q1 FY2026
- Non-US16.4%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 3 | 16.4% |
Revenue by Product & Service Category - Q1 FY2026
- Concentrate Products0%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Concentrate Products | $ 17 | - |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Rockwell Medical Inc
Rockwell Medical Inc. is a pharmaceutical company that specializes in the development and commercialization of innovative, clinically proven drug therapies and medical devices for the treatment of diseases related to iron deficiency and hemodialysis.
Founded in 1995, Rockwell Medical is headquartered in Wixom, Michigan, and has established itself as a leading player in the healthcare industry. The company's mission is to improve the lives of patients suffering from iron deficiency and chronic kidney disease through the development of ground-breaking products and therapies.
One of Rockwell Medical's key areas of focus is iron deficiency, a condition characterized by low levels of iron in the body. Iron deficiency can lead to anemia, a serious health condition that affects millions of people worldwide. Rockwell Medical has developed an advanced iron replacement therapy called Triferic, which is administered intravenously to patients with chronic kidney disease who are receiving hemodialysis. Triferic is unique because it directly targets the iron loss that occurs during dialysis treatment.
In addition to Triferic, Rockwell Medical has also developed other innovative pharmaceutical products targeting iron deficiency, including Calcitriol, an active form of Vitamin D that helps in the management of secondary hyperparathyroidism, a common complication of chronic kidney disease.
Rockwell Medical's commitment to excellence is evident in its state-of-the-art manufacturing facilities and rigorous quality control processes. The company operates a fully integrated manufacturing facility in Wixom, Michigan, where it produces its pharmaceutical products under strict adherence to regulatory guidelines. This vertical integration allows Rockwell Medical to have greater control over the manufacturing process, ensuring the highest quality standards are met.
Furthermore, Rockwell Medical has an experienced and dedicated team of scientists, researchers, and healthcare professionals who are committed to advancing the field of nephrology and improving patient outcomes. The company invests significantly in research and development activities, continually striving to develop new and innovative therapies for patients with kidney disease.
Rockwell Medical also works closely with healthcare providers, dialysis centers, and hospitals to ensure its products are readily available to patients in need. It has established distribution partnerships with leading pharmaceutical distributors, enabling a wide distribution network across the United States and some international markets.
In summary, Rockwell Medical Inc. is a pharmaceutical company focused on developing and commercializing groundbreaking therapies for patients suffering from iron deficiency and chronic kidney disease. With its advanced products and commitment to research and innovation, Rockwell Medical is poised to make a significant impact on the healthcare industry and improve the lives of patients worldwide.
Founded in 1995, Rockwell Medical is headquartered in Wixom, Michigan, and has established itself as a leading player in the healthcare industry. The company's mission is to improve the lives of patients suffering from iron deficiency and chronic kidney disease through the development of ground-breaking products and therapies.
One of Rockwell Medical's key areas of focus is iron deficiency, a condition characterized by low levels of iron in the body. Iron deficiency can lead to anemia, a serious health condition that affects millions of people worldwide. Rockwell Medical has developed an advanced iron replacement therapy called Triferic, which is administered intravenously to patients with chronic kidney disease who are receiving hemodialysis. Triferic is unique because it directly targets the iron loss that occurs during dialysis treatment.
In addition to Triferic, Rockwell Medical has also developed other innovative pharmaceutical products targeting iron deficiency, including Calcitriol, an active form of Vitamin D that helps in the management of secondary hyperparathyroidism, a common complication of chronic kidney disease.
Rockwell Medical's commitment to excellence is evident in its state-of-the-art manufacturing facilities and rigorous quality control processes. The company operates a fully integrated manufacturing facility in Wixom, Michigan, where it produces its pharmaceutical products under strict adherence to regulatory guidelines. This vertical integration allows Rockwell Medical to have greater control over the manufacturing process, ensuring the highest quality standards are met.
Furthermore, Rockwell Medical has an experienced and dedicated team of scientists, researchers, and healthcare professionals who are committed to advancing the field of nephrology and improving patient outcomes. The company invests significantly in research and development activities, continually striving to develop new and innovative therapies for patients with kidney disease.
Rockwell Medical also works closely with healthcare providers, dialysis centers, and hospitals to ensure its products are readily available to patients in need. It has established distribution partnerships with leading pharmaceutical distributors, enabling a wide distribution network across the United States and some international markets.
In summary, Rockwell Medical Inc. is a pharmaceutical company focused on developing and commercializing groundbreaking therapies for patients suffering from iron deficiency and chronic kidney disease. With its advanced products and commitment to research and innovation, Rockwell Medical is poised to make a significant impact on the healthcare industry and improve the lives of patients worldwide.
Rockwell Medical Inc. is a biotechnology company primarily focused on developing and delivering innovative products and services for patients undergoing dialysis, as well as other medical applications. The companys offerings can be categorized into multiple segments, primarily centering around pharmaceuticals, renal products, and a suite of technologies aimed at improving patient care.
1. Pharmaceutical Products
Rockwell Medical has developed pharmaceuticals that address the needs of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The key products include:
- Triferic: A unique iron replacement therapy intended for patients undergoing hemodialysis. Triferic is designed to deliver iron in a form that can be utilized by the body without the side effects commonly associated with iron supplements. This product aims to address iron deficiency anemia, which is prevalent among dialysis patients, helping to improve hemoglobin levels and overall patient health.
- Other pharmaceuticals: The company may also be involved in developing additional agents that could aid in correcting secondary complications associated with renal disorders, which may encompass pharmaceuticals for managing mineral and bone disorders and treatments for anemia related to kidney disease.
Dialysis Products
Rockwell Medical produces a range of products tailored for hemodialysis, primarily focusing on improving the safety and efficacy of dialysis treatments. These could include:
- Dialysate solutions: A critical component of the dialysis process, dialysate solutions play a vital role in filtering waste from a patient’s blood during treatment. Rockwell may offer various formulations designed to meet the specific electrolyte and fluid needs of patients.
- Access products: Devices and accessories that facilitate the safe and efficient vascular access for hemodialysis, ensuring patients can undergo treatments with minimal complications.
Renal Technologies and Services
The company may also offer various technologies and services aimed at enhancing patient management and care:
- Clinical Services: Rockwell Medical might provide consulting services to dialysis centers focusing on improving patient outcomes, optimizing treatment protocols, and ensuring adherence to industry regulations and best practices.
- Educational Programs: To support healthcare professionals and patients alike, the company likely engages in providing educational resources and training about kidney disease management, treatment options, and advancements in dialysis care.
- Research and Development Services: Rockwell is committed to the ongoing R&D of innovative therapies and products that can significantly impact kidney health and management, potentially collaborating with other organizations or institutions to advance clinical knowledge in this area.
Distribution and Supply Chain
As a part of its service offerings, Rockwell Medical is involved in the distribution of its products, which includes ensuring that healthcare providers have timely access to the necessary materials for patient treatment. This may involve logistics management, supply chain solutions, and partnerships with healthcare facilities.
Value-Added Services
The company may provide additional services such as post-sale support, which ensures that healthcare providers are well-equipped to use Rockwell’s products effectively. This could include technical support, product training, and consultation on optimizing the use of their solutions in clinical settings.
Conclusion
Rockwell Medical Inc. is dedicated to addressing the critical needs of patients with chronic kidney disease through a comprehensive range of pharmaceutical products, dialysis solutions, and supporting services. By focusing on innovative therapies and improving patient care throughout the dialysis process, the company aims to enhance the quality of life for patients experiencing kidney-related ailments.
1. Pharmaceutical Products
Rockwell Medical has developed pharmaceuticals that address the needs of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The key products include:
- Triferic: A unique iron replacement therapy intended for patients undergoing hemodialysis. Triferic is designed to deliver iron in a form that can be utilized by the body without the side effects commonly associated with iron supplements. This product aims to address iron deficiency anemia, which is prevalent among dialysis patients, helping to improve hemoglobin levels and overall patient health.
- Other pharmaceuticals: The company may also be involved in developing additional agents that could aid in correcting secondary complications associated with renal disorders, which may encompass pharmaceuticals for managing mineral and bone disorders and treatments for anemia related to kidney disease.
Dialysis Products
Rockwell Medical produces a range of products tailored for hemodialysis, primarily focusing on improving the safety and efficacy of dialysis treatments. These could include:
- Dialysate solutions: A critical component of the dialysis process, dialysate solutions play a vital role in filtering waste from a patient’s blood during treatment. Rockwell may offer various formulations designed to meet the specific electrolyte and fluid needs of patients.
- Access products: Devices and accessories that facilitate the safe and efficient vascular access for hemodialysis, ensuring patients can undergo treatments with minimal complications.
Renal Technologies and Services
The company may also offer various technologies and services aimed at enhancing patient management and care:
- Clinical Services: Rockwell Medical might provide consulting services to dialysis centers focusing on improving patient outcomes, optimizing treatment protocols, and ensuring adherence to industry regulations and best practices.
- Educational Programs: To support healthcare professionals and patients alike, the company likely engages in providing educational resources and training about kidney disease management, treatment options, and advancements in dialysis care.
- Research and Development Services: Rockwell is committed to the ongoing R&D of innovative therapies and products that can significantly impact kidney health and management, potentially collaborating with other organizations or institutions to advance clinical knowledge in this area.
Distribution and Supply Chain
As a part of its service offerings, Rockwell Medical is involved in the distribution of its products, which includes ensuring that healthcare providers have timely access to the necessary materials for patient treatment. This may involve logistics management, supply chain solutions, and partnerships with healthcare facilities.
Value-Added Services
The company may provide additional services such as post-sale support, which ensures that healthcare providers are well-equipped to use Rockwell’s products effectively. This could include technical support, product training, and consultation on optimizing the use of their solutions in clinical settings.
Conclusion
Rockwell Medical Inc. is dedicated to addressing the critical needs of patients with chronic kidney disease through a comprehensive range of pharmaceutical products, dialysis solutions, and supporting services. By focusing on innovative therapies and improving patient care throughout the dialysis process, the company aims to enhance the quality of life for patients experiencing kidney-related ailments.